Whelton, Andrew <br/><br/>
The coxib conundrum: lessons from the rise and fall of rofecoxib.  [electronic resource] 

 -  American journal of therapeutics   
 - 417-21 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1075-2765 
<br/><br/><label>Standard No.: </label>10.1097/01.mjt.0000149719.58535.b0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Pressure--drug effects<br/>Cardiovascular Diseases--chemically induced<br/>Cohort Studies<br/>Cyclooxygenase Inhibitors--adverse effects<br/>Drug Industry--ethics<br/>Drug and Narcotic Control<br/>Humans<br/>Lactones--adverse effects<br/>Peptic Ulcer--chemically induced<br/>Product Surveillance, Postmarketing<br/>Randomized Controlled Trials as Topic<br/>Sulfones--adverse effects<br/>United States<br/>United States Food and Drug Administration